Shannon Gadd, BCACP, PharmD is an assistant professor and clinical pharmacist with the University of Utah Division of Physician Assistant Studies. She has a strong interest in pharmacotherapy education and interprofessional team-based care. Her clinical pharmacist role is part of the University of Utah's South Main Clinic, a mission based, inter-professional clinic. Prior to her current position, she completed a pharmacy residency and fellowship with the University of Utah and practiced as a clinical pharmacist in the Salt Lake Valley. In her leisure time, she enjoys spending time with her family, snowmobiling, and playing tennis.
Education History
Fellowship |
University of Utah College of Pharmacy |
Clinical Fellow |
---|---|---|
University of Utah Health |
Resident | |
Professional Medical |
University of Utah College of Pharmacy |
PharmD |
Brigham Young University |
BS |
Selected Publications
Journal Article
- Young D, Gadd S, Ashmead P, Abbinanti A, Pinnock E, Do Lam TL, Turner K (2023). Assessing the impact of a leadership and advocacy elective course in a college of pharmacy curriculum. Curr Pharm Teach Learn, 15(9), 843-847. (Read full article)
- Young DC, Gadd S, Ashmead P, Abbinanti A, Pinnock E, Do Lam TL, Turner K (2023). Assessing impact of a leadership and advocacy elective course in a college of pharmacy curriculum. Currents in Pharmacy Teaching and Learning, 15(9), 843-847.
- Gadd S, Cox N, Slager S, Pinnock E, Mitchell M, Turner K (2023). Assessing the impact of a payor-funded embedded clinical pharmacist on patient and provider satisfaction in a private primary care practice. Am J Health Syst Pharm, 80(12), 742-749. (Read full article)
- Gadd S, Lopez CE, Nelson CA, Le TQ, Valle-Oseguera CS, Cox N, Buu J, Turner K (2021). Identifying key roles of the pharmacy technician in primary care settings. Am J Health Syst Pharm, 79(6), 460-466. (Read full article)
- Gadd S, Cox N, Samuelson J, Kenney A, Turner K, Cochran G (2020). Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective. Ther Drug Monit, 43(1), 35-41. (Read full article)